• Frontier investable areas in brain health with PsyMed Ventures

  • Feb 25 2025
  • Length: 50 mins
  • Podcast

Frontier investable areas in brain health with PsyMed Ventures

Listen for free

View show details

  • Summary

  • Greg and Matias sit down with Brooks Leitner, the newest partner at PsyMed Ventures, to explore the future of brain and mental health investing. Brooks, an MD/PhD with deep experience from Yale and the NIH, shares his insights on how a human-first approach is reshaping neuroscience innovation and venture investing.

    In this episode, we discuss:

    • Broadening the Thesis: Evolving from a psychedelics-only focus to a comprehensive neuro investment strategy.
    • Human-First Research: Shifting from animal models to clinical insights for better brain therapies.
    • Key Investment Areas: Therapeutics, medical devices, diagnostics, consumer health, and AI-enabled care platforms.
    • Early-Stage Conviction: Leveraging a prepared mind to spot breakthrough opportunities.
    • Personal & Future Insights: Leadership challenges and the vision for the future of neuro investing.

    Credits:

    Created by Greg Kubin and Matias Serebrinsky
    Host: Matias Serebrinsky & Greg Kubin
    Produced by Jonathan A. Davis, Nico V. Rey & Caitlin Ner

    Find us at businesstrip.fm and psymed.ventures
    Follow us on Instagram and Twitter!
    Theme music by Dorian Love
    Additional Music: Distant Daze by Zack Frank
    Show More Show Less
Show More Show Less

What listeners say about Frontier investable areas in brain health with PsyMed Ventures

Average Customer Ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com.au reviews

Amazon Reviews
No Reviews are Available
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.